These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 36015138)

  • 1. Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and Response.
    Kamath A; Srinivasamurthy SK; Chowta MN; Ullal SD; Daali Y; Chakradhara Rao US
    Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species.
    van Groen BD; Nicolaï J; Kuik AC; Van Cruchten S; van Peer E; Smits A; Schmidt S; de Wildt SN; Allegaert K; De Schaepdrijver L; Annaert P; Badée J
    Pharmacol Rev; 2021 Apr; 73(2):597-678. PubMed ID: 33608409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics and application in pediatrics.
    Neyro V; Jacqz-Aigrain E; Adam de Beaumais T
    Therapie; 2018 Apr; 73(2):157-163. PubMed ID: 29530313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics.
    Kiss M; Mbasu R; Nicolaï J; Barnouin K; Kotian A; Mooij MG; Kist N; Wijnen RMH; Ungell AL; Cutler P; Russel FGM; de Wildt SN
    Drug Metab Dispos; 2021 Dec; 49(12):1038-1046. PubMed ID: 34548392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition.
    Shi S; Li Y
    Curr Drug Metab; 2014; 15(10):915-41. PubMed ID: 25828591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogeny and drug metabolism in newborns.
    Dotta A; Chukhlantseva N
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.
    Naji-Talakar S; Sharma S; Martin LA; Barnhart D; Prasad B
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):273-289. PubMed ID: 33256492
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.
    Mooij MG; Nies AT; Knibbe CA; Schaeffeler E; Tibboel D; Schwab M; de Wildt SN
    Clin Pharmacokinet; 2016 May; 55(5):507-24. PubMed ID: 26410689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.
    Huang Y
    Cancer Metastasis Rev; 2007 Mar; 26(1):183-201. PubMed ID: 17323126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental pharmacogenomics.
    Neville KA; Becker ML; Goldman JL; Kearns GL
    Paediatr Anaesth; 2011 Mar; 21(3):255-65. PubMed ID: 21320234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.
    Rodieux F; Gotta V; Pfister M; van den Anker JN
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S173-92. PubMed ID: 27385174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of genetic polymorphisms in drug transporters for pharmacotherapy.
    Kerb R
    Cancer Lett; 2006 Mar; 234(1):4-33. PubMed ID: 16504381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development.
    Lee W; Lockhart AC; Kim RB; Rothenberg ML
    Oncologist; 2005 Feb; 10(2):104-11. PubMed ID: 15709212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of DNA methylation on ADME gene expression, drug disposition, and efficacy.
    Hao X; Li Y; Bian J; Zhang Y; He S; Yu F; Feng Y; Huang L
    Drug Metab Rev; 2022 May; 54(2):194-206. PubMed ID: 35412942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics in cancer treatment.
    Nagasubramanian R; Innocenti F; Ratain MJ
    Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes.
    Yoo HD; Lee YB
    Arch Pharm Res; 2011 Nov; 34(11):1817-28. PubMed ID: 22139683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.
    Ahmed S; Zhou Z; Zhou J; Chen SQ
    Genomics Proteomics Bioinformatics; 2016 Oct; 14(5):298-313. PubMed ID: 27729266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental pharmacokinetics.
    van den Anker JN; Schwab M; Kearns GL
    Handb Exp Pharmacol; 2011; 205():51-75. PubMed ID: 21882105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia.
    Megias-Vericat JE; Martinez-Cuadron D; Herrero MJ; Alino SF; Poveda JL; Sanz MA; Montesinos P
    Curr Drug Metab; 2018; 19(1):55-74. PubMed ID: 29090664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment.
    Ekhart C; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
    Cancer Treat Rev; 2009 Feb; 35(1):18-31. PubMed ID: 18771857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.